Cargando…
Time- and Sex-Dependent Effects of Fingolimod Treatment in a Mouse Model of Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common cause of dementia. Fingolimod has previously shown beneficial effects in different animal models of AD. However, it has shown contradictory effects when it has been applied at early disease stages. Our objective was to evaluate fingolimod in two different...
Autores principales: | Bascuñana, Pablo, Brackhan, Mirjam, Möhle, Luisa, Wu, Jingyun, Brüning, Thomas, Eiriz, Ivan, Jansone, Baiba, Pahnke, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953119/ https://www.ncbi.nlm.nih.gov/pubmed/36830699 http://dx.doi.org/10.3390/biom13020331 |
Ejemplares similares
-
Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis
por: Bascuñana, Pablo, et al.
Publicado: (2020) -
A New Tool for the Analysis of the Effect of Intracerebrally Injected Anti-Amyloid-β Compounds
por: Upīte, Jolanta, et al.
Publicado: (2021) -
ABC Transporter C1 Prevents Dimethyl Fumarate from Targeting Alzheimer’s Disease
por: Möhle, Luisa, et al.
Publicado: (2023) -
Detection and Prediction of Mild Cognitive Impairment in Alzheimer’s Disease Mice
por: Rai, Surya Prakash, et al.
Publicado: (2020) -
Machine Learning-Supported Analyses Improve Quantitative Histological Assessments of Amyloid-β Deposits and Activated Microglia
por: Bascuñana, Pablo, et al.
Publicado: (2021)